Coronary atherosclerosis is a diffuse vascular process and a life-long disease where optimal medical therapy is the foundation for all patients with CAD. Primary PCI is the preferred therapy in STEMI and early angiography, followed by revascularization, the preferred therapy in NSTEACS. In stable ischemic heart disease, therapy must be individualized for each patient whether PCI, CABG or an initial MT approach is chosen.

Gregg W. Stone, MD
Professor of Medicine at Columbia University College of Physicians and Surgeons
Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center